Search Blog
Categories
November 2013
M T W T F S S
« Oct   Dec »
 123
45678910
11121314151617
18192021222324
252627282930  

Tags

HOLX, GMCR, ONCY and ZNGA added to NASDAQ Active Stock Watch List at EPR

admin

By Equity Profile Report

New York, NY – (ACCESSWIRE) – 11/21/2013 – Equity Profile Report initiates its NASDAQ Active Stock Weekly Watch List adding Hologic Inc. (NASDAQ:HOLX), Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR), Oncolytics Biotech Inc. (NASDAQ:ONCY), and Zynga, Inc. (NASDAQ:ZNGA) 

Hologic Inc. (NASDAQ:HOLX) a company that develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women is currently up (+3.10%) on 7,548,830 shares traded after HOLOGIC INC Filed SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits. Hologic Inc. (NASDAQ:HOLX) is currently up (+24.86%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Hologic Inc. (NASDAQ:HOLX)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=HOLX&SubId=AW 

Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR) a company that engages in the specialty coffee and coffeemaker businesses in the United States and Canada is currently up (+15.09%) on 5,981,688 shares traded after GREEN MOUNTAIN COFFEE ROASTERS INC Filed SEC form 10-K/A, Annual Report. Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR) is currently up (+153.77%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=GMCR&SubId=AW 

Oncolytics Biotech Inc. (NASDAQ:ONCY) a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers is currently down (-10.71%) on 1,733,570 shares traded after Oncolytics Biotech announced data from Reo study of Reolysin. Oncolytics Biotech Inc. (NASDAQ:ONCY) is currently down (-52.94%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Oncolytics Biotech Inc. (NASDAQ:ONCY)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=ONCY&SubId=AW 

Zynga, Inc. (NASDAQ:ZNGA) a company that develops, markets, and operates online social games as live services on the Internet, social networking sites, and mobile platforms in the United States and internationally is currently up (+4.22%) on 15,041,874 shares traded. Zynga, Inc. (NASDAQ:ZNGA) is currently up (+100.45%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Zynga, Inc. (NASDAQ:ZNGA)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=ZNGA&SubId=AW 

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.equityprofilereport.com/

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com